These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38828510)
1. N-terminal pro-B-type natriuretic peptide and pulmonary echography are predictors of acute heart failure needing early mechanical ventilation in acute coronary syndrome. Cristo-Ropero MJ; Garcia-Rubira JC; Rivera-Rabanal FJ; Seoane-García T; Madrona-Jiménez L; Izquierdo-Bajo Á; Hernández-Meneses B; Vilches-Arenas A; Hidalgo-Urbano R Coron Artery Dis; 2024 Nov; 35(7):556-563. PubMed ID: 38828510 [TBL] [Abstract][Full Text] [Related]
2. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome. Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome]. Liu WX; Zhao H Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547 [TBL] [Abstract][Full Text] [Related]
5. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908 [TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
7. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055 [TBL] [Abstract][Full Text] [Related]
8. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score. Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II). Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes. Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction. He PC; Duan CY; Liu YH; Wei XB; Lin SG BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618 [TBL] [Abstract][Full Text] [Related]
13. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery. Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704 [TBL] [Abstract][Full Text] [Related]
14. Utility of pulmonary echography with a handheld ultrasound device in patients with acute coronary syndrome. Cristo Ropero MJ; Rivera Rabanal FJ; Seoane García T; Madrona Jiménez L; Izquierdo Bajo Á; Hidalgo Urbano R; Garcia-Rubira JC; Vilches Arenas A Intern Emerg Med; 2023 Jan; 18(1):249-255. PubMed ID: 36184684 [TBL] [Abstract][Full Text] [Related]
16. Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era. Onda T; Inoue K; Suwa S; Nishizaki Y; Kasai T; Kimura Y; Fukuda K; Okai I; Fujiwara Y; Matsuoka J; Sumiyoshi M; Daida H Int J Cardiol; 2016 Sep; 219():180-5. PubMed ID: 27327504 [TBL] [Abstract][Full Text] [Related]
17. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956 [TBL] [Abstract][Full Text] [Related]
18. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication. Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224 [TBL] [Abstract][Full Text] [Related]
19. Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels. Jarai R; Iordanova N; Jarai R; Jarai F; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K Wien Klin Wochenschr; 2007; 119(21-22):626-32. PubMed ID: 18043882 [TBL] [Abstract][Full Text] [Related]
20. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study. He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]